AC Immune SA - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAC Immune SA

AC Immune SA(ACIU)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

atherosclerosis

,

intracranial arteriosclerosis

,

fallopian tube neoplasms

,

healthy volunteers/patients

,

,

,

squamous cell carcinoma

,

hypersensitivity

,

non-small-cell lung carcinoma

,

triple negative breast neoplasms

,

ovarian epithelial carcinoma

,

renal cell carcinoma

,

,

peanut hypersensitivity

,

allergic rhinitis

,

,

basal cell carcinoma

,

squamous cell carcinoma of head and neck

,

merkel cell carcinoma

,

neoplasm metastasis

,

basal cell neoplasms

,

,

,

,

adenocarcinoma of lung

,

milk hypersensitivity

,

multiple myeloma

,

plasma cell neoplasms

,

smoldering multiple myeloma

,

paraproteinemias

,

monoclonal gammopathy of undetermined significance

,

prostatic neoplasms

,

colorectal neoplasms

,

head and neck neoplasms

,

ovarian neoplasms

,

retinal diseases

,

diabetic retinopathy

,

,

,

protein-losing enteropathies

,

intestinal diseases

,

myositis ossificans

,

vitreous hemorrhage

,

type 2 diabetes mellitus

,

hyperlipidemias

,

diabetes mellitus

,

macular degeneration

,

,

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use